Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

1 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Screening

- 26/9/17 - 1 formulario, 15 itemgroups, 61 items, 1 idioma
Itemgroups: General Information, Informed Consent, Demography, Vital signs, Date of onset of symptoms of parkinson´s disease, Modified Hoehn and Yahr Parkinsons Disease Staging, Significant medical / surgical history and physical examination, Details on Significant medical or surgical condition, Prior anti-parkinson medication, Details on prior anti-parkinson medication, Other prior medication (excluding anti-parkinson medication), Details on other prior medication (excluding anti-parkinson medication), Inclusion Criteria, Exclusion Criteria, Laboratory tests
Study ID: 101468/125 Clinical Study ID: SKF-101468/125 Study Title: A double-blind, multicentre, flexible dose, L-dopa controlled study of ropinirole to investigate A) neuroprotective effect as measured by 3D PET scanning, and B) ophthalmological safety, in patients with early Parkinson’s disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial